Eli Lilly (LLY) Goodwill (2009 - 2026)
Eli Lilly posted quarterly Goodwill of $6.1 billion for Q1 2026, up 6.23% year-on-year from $5.8 billion in Q1 2025, and up 3.93% on a QoQ basis from $5.9 billion in Q4 2025.
Eli Lilly (LLY) has 18 years of Goodwill data on file, last reported at $6.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Goodwill rose 6.23% year-over-year to $6.1 billion; the trailing twelve-month figure through Mar 2026 stood at $6.1 billion (up 6.23% YoY), and the FY2025 full-year result was $5.9 billion, up 2.22% from the prior year.
- Goodwill for Q1 2026 stood at $6.1 billion, up from $5.9 billion in the prior quarter.
- Across five years, Goodwill topped out at $6.1 billion in Q1 2026 and bottomed at $3.9 billion in Q3 2022.
- The 5-year median for Goodwill is $4.9 billion (2023), against an average of $5.0 billion.
- The widest annual swing landed in 2024, when Goodwill soared 41.42%; it then grew 0.04% in 2025.
- A 5-year view of Goodwill shows it stood at $4.1 billion in 2022, then advanced by 21.28% to $4.9 billion in 2023, then climbed by 16.81% to $5.8 billion in 2024, then advanced by 2.22% to $5.9 billion in 2025, then grew by 3.93% to $6.1 billion in 2026.
- The last three Goodwill figures came in at $6.1 billion (Q1 2026), $5.9 billion (Q4 2025), and $5.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.13 Bn |
| Dec 31, 2025 | 5.90 Bn |
| Sep 30, 2025 | 5.90 Bn |
| Jun 30, 2025 | 5.77 Bn |
| Mar 31, 2025 | 5.77 Bn |
| Dec 31, 2024 | 5.77 Bn |
| Sep 30, 2024 | 5.77 Bn |
| Jun 30, 2024 | 5.77 Bn |
| Mar 31, 2024 | 4.94 Bn |
| Dec 31, 2023 | 4.94 Bn |
| Sep 30, 2023 | 4.09 Bn |
| Jun 30, 2023 | 4.08 Bn |
| Mar 31, 2023 | 4.07 Bn |
| Dec 31, 2022 | 4.07 Bn |
| Sep 30, 2022 | 3.89 Bn |
| Jun 30, 2022 | 3.89 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 3.89 Bn |
| Sep 30, 2021 | 3.88 Bn |
| Jun 30, 2021 | 3.88 Bn |
| Mar 31, 2021 | 3.88 Bn |
| Dec 31, 2020 | 3.77 Bn |
| Sep 30, 2020 | 3.73 Bn |
| Jun 30, 2020 | 3.72 Bn |
| Mar 31, 2020 | 3.78 Bn |
| Dec 31, 2019 | 3.68 Bn |
| Sep 30, 2019 | 3.77 Bn |
| Jun 30, 2019 | 3.82 Bn |
| Mar 31, 2019 | 3.86 Bn |
| Dec 31, 2018 | 1.37 Bn |
| Sep 30, 2018 | 4.36 Bn |
| Jun 30, 2018 | 4.33 Bn |
| Mar 31, 2018 | 4.41 Bn |
| Dec 31, 2017 | 4.37 Bn |
| Sep 30, 2017 | 4.37 Bn |
| Jun 30, 2017 | 4.29 Bn |
| Mar 31, 2017 | 4.19 Bn |
| Dec 31, 2016 | 3.97 Bn |
| Sep 30, 2016 | 4.01 Bn |
| Jun 30, 2016 | 4.03 Bn |
| Mar 31, 2016 | 4.05 Bn |
| Dec 31, 2015 | 4.04 Bn |
| Sep 30, 2015 | 4.05 Bn |
| Jun 30, 2015 | 4.02 Bn |
| Mar 31, 2015 | 3.95 Bn |
| Dec 31, 2014 | 1.76 Bn |
| Dec 31, 2013 | 1.52 Bn |
| Dec 31, 2012 | 1.50 Bn |
| Dec 31, 2011 | 1.43 Bn |
| Dec 31, 2010 | 1.42 Bn |
| Dec 31, 2009 | 1.18 Bn |